NCT01046123
Breast Cancer Type: HER2+, HR+ & HER2-negative, Triple Negative
Hormone Mutations: ER+, PR+
Other Mutations: 
Breast Cancer Tissue: 
Recruitment Status: Active, not recruiting
Not Applicable
Drug Category: Radiation therapy

Key Eligibility Criteria:

Gender: All
Age: 18 Years to 100 Years (Adult, Older Adult)
Location of Metastases: Brain
Additional Notes: Patient must have 1-10 brain metastases with the maximum diameter of largest metastasis less than or equal to 3 cm
Exclusions: Patient with extracranial disease that not well-controlled; Patient with previous cranial radiotherapy; Patient with brainstem metastases or metastases within 0.7 cm of the optic chiasm, brainstem or optic nerves
https://ClinicalTrials.gov/show/NCT01046123